Evolving preferences of HCPs during the pandemic have put an emphasis on learning new skillsets for pharma reps.
Jim Whitaker
Advertisement
Articles by Jim Whitaker
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Bausch + Lomb Appoints Thomas Appio as Interim CEO
2
The Manufacturing Issues That Continue to Contribute to Drug Shortages
3
AI and the Apprenticeship Gap: Rethinking Work for Experienced and Early-Career Talent in Professional Services
4
FDA Approves Tecentriq for Stage III dMMR Colon Cancer
5